1. Antihypertensive drugs in COVID-19 infection.
- Author
-
Pinto-Sietsma SJ, Flossdorf M, Buchholz VR, Offerhaus J, Bleijendaal H, Beudel M, Volders PGA, Ter Bekke RMA, Dormans T, Zwetsloot PP, de Jager P, Massberg S, Rämer P, Wendtner C, Hoffmann E, Rothe K, Feihl S, Kessler T, Pinto YM, and Schunkert H
- Subjects
- Adrenergic beta-Antagonists administration & dosage, Angiotensin Receptor Antagonists administration & dosage, Angiotensin-Converting Enzyme Inhibitors administration & dosage, Antihypertensive Agents adverse effects, COVID-19, Calcium Channel Blockers administration & dosage, Coronavirus Infections diagnosis, Coronavirus Infections mortality, Diuretics administration & dosage, Drug Administration Schedule, Germany, Hospitalization, Humans, Hypertension diagnosis, Hypertension mortality, Netherlands, Pandemics, Pneumonia, Viral diagnosis, Pneumonia, Viral mortality, Protective Factors, Risk Factors, Treatment Outcome, Antihypertensive Agents administration & dosage, Coronavirus Infections therapy, Hypertension drug therapy, Pneumonia, Viral therapy
- Published
- 2020
- Full Text
- View/download PDF